Data from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/Her2-Negative Advanced Breast Cancer After Progression on Aromatase Inhibitor
AuthID
P-013-6E7
P-013-6E7